Funder: Bill and Melinda Gates Foundation
Due Dates: April 1, 2026 (Letter of Inquiry)
Funding Amounts: Up to $5,000,000 USD per project for up to 3 years; exploratory projects with lower budgets prioritized.
Summary: Funds interdisciplinary research to discover and develop novel antibiotics targeting multidrug-resistant Gram-negative bacteria, especially Klebsiella pneumoniae.
Key Information: Applicants must agree to consortium data sharing and funder-specific terms; only one application as lead applicant per person.